A pragmatic randomized controlled trial exploring the relationship between pulse number and response to repetitive transcranial magnetic stimulation treatment in depression.

BACKGROUND: Repetitive transcranial magnetic stimulation treatment (rTMS) is an effective treatment for depression but the optimal methods of administration have yet to be determined. In particular, it is unclear whether there is a relationship between elements of the dose of stimulation (i.e., number of pulses) and clinical response. To address one aspect of dose, we conducted a trial comparing standard and high dose versions of high frequency left sided and low frequency right sided rTMS protocols (left standard = 50 trains, left high = 125 trains, right standard = 20 min, right high = 60 min, all per day in a single session). METHOD: 300 patients with treatment resistant depression were enrolled in a four arm randomized controlled trial across a four week time period. The primary outcome assessment was a comparison of response and remission rates on data from the 17-item Hamilton Rating Scale for Depression Rating Scale (HRSD-17). RESULTS: The rate of response exceeded 45% in all groups. There was no significant difference between groups on initial analysis of the primary or secondary outcome measures (response rates: standard left = 52.5%, high left = 47.3%, standard right = 49.1%, high right = 48.4%). There was a greater remission rate with high compared to moderate dose left sided treatment when controlling for illness duration. We also found significant improvements in quality of life across all treatment groups. Illness duration was weakly associated with response. CONCLUSIONS: There was no consistent association between the antidepressant effect of rTMS and the number of TMS pulses provided across the ranges investigated in this study. Increasing TMS pulse number in individual sessions seems unlikely to be a method to substantially improve clinical outcomes, and future research should explore alternative means of improving clinical response. The study was registered on the Australian and New Zealand Clinical Trials Register (ACTRN12612000321842) https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=362063&isReview=true.

Equivalent beneficial effects of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in a large randomized trial in treatment-resistant major depression.

Repetitive transcranial magnetic stimulation treatment (rTMS) is an effective treatment for depression but the optimal methods of administration have yet to be determined. Recent studies have produced conflicting results as to whether unilateral rTMS is more or less effective than sequentially applied bilateral rTMS. To address this we conducted a trial comparing sequential bilateral rTMS to right-sided unilateral rTMS using a priming protocol. Patients with treatment-resistant depression (n = 179) were enrolled in a two-arm randomized controlled trial across a 4-wk time period. The primary outcome assessment was the Hamilton Depression Rating Scale. Overall, there was a substantial response rate of >50% (and a 40% remission rate); however, there were no significant differences in clinical response between the two treatment groups. rTMS was well tolerated with a very low discontinuation rate. There was no relationship between response in the current trial and previous response, or non-response, to electroconvulsive therapy. We found no significant differences in clinical response between sequential bilateral rTMS and right-sided unilateral rTMS applied with a priming protocol. The results of this study do not support superior efficacy of bilateral rTMS and instead suggest that other approaches should be explored to increase treatment efficacy.

Computer-simulated radiation dose reduction for abdominal multidetector CT of pediatric patients.

OBJECTIVE: Limiting CT radiation dose is especially critical when imaging children. The purpose of our study was to modify and test an accurate and safe tool for evaluating systematic dose reduction for abdominal multidetector CT (MDCT) in pediatric patients. MATERIALS AND METHODS: After validating the computer-simulation technique with a water phantom, we subjected the original digital scanning data for 26 contrast-enhanced abdominal MDCT scans (120 mA) obtained in infants and children (age range, 1 month-9 years; mean age, 3.1 years) to simulated tube current reduction (100, 80, 60, and 40 mA) by adding noise. this procedure created four additional examinations per child that were identical to the originals except for image noise. The 130 examinations were scored randomly, independently, and without prior knowledge of the children's diagnoses by three radiologists for depiction of high-visibility structures, such as adrenal glands and fat in the intrahepatic falciform ligament, and low-visibility structures, such as the extrahepatic hepatic artery, small intrahepatic vessels, and common bile duct. Aligned rank and Wilcoxon's signed rank tests were used for statistical analyses. RESULTS: Simulated tube current reduction significantly affected the detection of low-visibility structures (p < 0.001). Reduced detection in low-visibility structures was evident at a level less than or equal to 80 mA. No loss of detection in high-visibility structures was found at any tube current level (p > 0.5). CONCLUSION: The results of this computer simulation suggest that accurate abdominal MDCT can be performed in pediatric patients using substantially reduced radiation, depending on the indication for imaging. (In our case, the reduction was between 33% and 67%, depending on whether a high-visibility or low-visibility structure was being assessed.) This simulation technology can be applied to MDCT of other organ systems for systematic evaluation of radiation dose reduction.